From an internet news site yesterday:

>Shares of Martek Biosciences Corp. (NASDAQ:MATK) soared 25 percent on
> >Thursday after the maker of nutritional products said infant formulas
> >sold by units of Bristol-Myers Squibb Co. (NYSE:BMY) and Abbott
> >Laboratories Inc. (NYSE:ABT) would contain chemicals it makes.

That means both Mead-Johnson and Ross Labs formulas will have docosahexanoic
and arachidonic acids from Martek added to them.  The new, improved "more
like breast milk" formulas are to be available in the US in early February.

Kathy Dettwyler

_________________________________________________________________
Get your FREE download of MSN Explorer at http://explorer.msn.com/intl.asp.

             ***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html